Otros idiomas Auro Laboratories Limited

Acciones

AUROLAB6

INE292C01011

Diferido Bombay S.E. Otros sitios de cotización 11:39:49 17/05/2024			Varia. Cinco días.	Varia. 1 de enero.
226,8 ^INR	+5,00 %		-10,66 %	+75,41 %

30/03	Auro Laboratories Limited anuncia el cese de Kailash Chand Bubna como Director Independiente	CI
06/02	Auro Laboratories Limited informa de los resultados del tercer trimestre y de los nueve meses finalizados el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Auro Laboratories Limited Announces Cessation of Kailash Chand Bubna as Independent Director	30/03
Auro Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	06/02
Auro Laboratories Limited Appoints Shaan Jain as Chief Financial Officer	22/12
Auro Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Auro Laboratories Limited Announces the Resignation of Amit Mahipat Shah as Chief Financial Officer, Effective October 1, 2023	25/09/23
Auro Laboratories Limited Appoints Vishal Kailashchandra Jhunjhunwala as an Non-Executive & Independent Director	23/09/23
Auro Laboratories Plans to Spend INR400 Million to Expand Capacity of Metformin HCL Factory	24/08/23
Auro Laboratories Limited Announces Intimation Regarding Capacity Expansion	23/08/23
Auro Laboratories Limited Announces Resignation of Govardhan Das Agarwal as Director	23/08/23
Auro Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	31/07/23
Auro Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	16/05/23
Auro Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/02/23
Auro Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22
Auro Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	02/08/22
Auro Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	30/05/22
Auro Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/05/22
Auro Laboratories Limited Announces Management Changes	30/05/22
Auro Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	28/01/22
Auro Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	11/11/21
Auro Laboratories Limited Approves the Appointment of Kiran Kulkarni as the Whole-Time Director of the company	06/08/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Auro Laboratories Limited

Acciones

AUROLAB6

INE292C01011

Otros idiomas

Filtros